Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Pratley RE, Aroda VR, Lingvay I, et al
Neuroprotective Effects of Lixisenatide and Liraglutide in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinsons Disease
Know your patient
At 5mg/mL, the same 2mg dose is 40 units
Most commonly reported: Nausea (most common, particularly during dose escalation) Diarrhea Vomiting Constipation Abdominal discomfort These effects were generally mild to moderate in severity and tended to diminish as participants adjusted to the treatment, particularly when gradual dose escalation protocols were followed
One of the most potent treatments among those medications is the glucagon-like peptide-1 receptor agonists
US$ 23.82
US$ 25.09
US$ 24.93
